Small Cap New Highs: Hudson Pacific Properties (NYSE:HPP), Midstates Petroleum Company (NYSE:MPO), Gentiva Health Services (NASDAQ:GTIV), Greenbrier (NYSE:GBX), Entegris (NASDAQ:ENTG)

Hudson Pacific Properties, Inc. (NYSE:HPP) on 16 June 2014 announced it has signed a new lease at its 901 Market Street property in San Francisco with NerdWallet, Inc., the fast-growing startup that helps consumers make smart financial decisions. Hudson Pacific Properties Inc (NYSE:HPP) stock performance was 1.72% in last session and finished the day at $25.45. Traded volume was 1.06million shares in the last session … Continue reading Small Cap New Highs: Hudson Pacific Properties (NYSE:HPP), Midstates Petroleum Company (NYSE:MPO), Gentiva Health Services (NASDAQ:GTIV), Greenbrier (NYSE:GBX), Entegris (NASDAQ:ENTG)

Bluebirdbio BLUE NASDAQ BLUE

Healthcare Gainers: Gentiva Health Services (NASDAQ:GTIV), bluebird bio Inc (NASDAQ:BLUE), Celldex Therapeutics (NASDAQ:CLDX), Intercept Pharmaceuticals (NASDAQ:ICPT), Northwest Biotherapeutics (NASDAQ:NWBO)

Gentiva Health Services Inc. (NASDAQ:GTIV)’s rejection of the takeover proposal from Kindred Healthcare Inc. ( KND ) is hitting headlines and drawing investor attention to the healthcare space. Gentiva Health Services, Inc. (NASDAQ:GTIV) stock performance was -1.52% in last session and finished the day at $13.62. Traded volume was 1.47million shares in the last session and the average volume of the stock remained 471.48K shares. … Continue reading Healthcare Gainers: Gentiva Health Services (NASDAQ:GTIV), bluebird bio Inc (NASDAQ:BLUE), Celldex Therapeutics (NASDAQ:CLDX), Intercept Pharmaceuticals (NASDAQ:ICPT), Northwest Biotherapeutics (NASDAQ:NWBO)

Healthcare ACtive Stocks: Rexahn Pharmaceuticals (NYSEMKT:RNN), Eli Lilly (NYSE:LLY), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Gentiva Health Services (NASDAQ:GTIV)

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) said, “We continue to enroll patients in each of our three clinical trials as expected, and as planned for. By the end of 2014, we expect to achieve key milestones in each trial. In Q4 we expect to have data from our Phase I trial of Supinoxin in cancer patients with solid tumors. We are also scheduled to complete enrollment of … Continue reading Healthcare ACtive Stocks: Rexahn Pharmaceuticals (NYSEMKT:RNN), Eli Lilly (NYSE:LLY), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Gentiva Health Services (NASDAQ:GTIV)